Furthermore, this system enhances lymphocyte infiltration into tumour regions and, in combination with anti-PD-L1 drugs, effectively decreases the number of nonfunctional cells; thus, this system showed encouraging outcomes in various tumour models. This evidence concerns the gene CD274 and neoplasm.